a phase ii study of the lsd1 inhibitor bomedemstat in patients with polycythemia vera
Published 2 months ago • 159 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:43
updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
-
1:49
mechanism of action of bomedemstat
-
1:39
upcoming agents in et and pv
-
0:35
novel therapeutics in essential thrombocythemia
-
1:47
bomedemstat normalizes platelet count for essential thrombocythemia
-
32:32
sequencing on the aviti™ - the elements of freedom
-
6:15
1 of 4 | sequencing on the aviti™ - overview
-
10:02
2 of 4 | sequencing on the aviti™ - unique chemistry
-
3:05
recent updates in the mpn field: clinical trials, novel agents, and more
-
1:13
agents currently in clinical trial for the treatment of pv: rusfertide, sapablursen, and bomedemstat
-
3:29
unmet needs and therapeutic strategies in essential thrombocythemia
-
4:32
current trials in mpn in the uk and the launch of the mympnvoice app
-
3:30
introduction to immunity of ics
-
0:57
äkta™ start tutorial: unicorn™ start software overview
-
2:08
amphasoft 2.0 - introduction